Literature DB >> 6126002

Functional restoration of the traumatically injured spinal cord in cats by clonidine.

N E Naftchi.   

Abstract

The long-term, chronic, paralysis resulting from spinal cord injury in the cat has been reversed by the use of an alpha 2-adrenergic receptor agonist, clonidine. Administration of this drug resulted in "normalization" of sensory-motor and autonomic dysfunctions. Preliminary studies of the clonidine in humans with traumatically injured spinal cord indicate that autonomic dysreflexia can be controlled and spasticity minimized. The data suggest that biochemical and pharmacologic manipulation of receptors may ameliorate paralysis following traumatic injury to the spinal cord as well as to the brain and brainstem.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6126002     DOI: 10.1126/science.6126002

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  6 in total

1.  Clonidine in spinal cord injury.

Authors:  P W Nance; A H Shears; D M Nance
Journal:  Can Med Assoc J       Date:  1985-07-01       Impact factor: 8.262

2.  Differential modulation of crossed and uncrossed reflex pathways by clonidine in adult cats following complete spinal cord injury.

Authors:  Alain Frigon; Michael D Johnson; C J Heckman
Journal:  J Physiol       Date:  2012-01-04       Impact factor: 5.182

3.  Clonidine prolongs canine tetracaine spinal anaesthesia.

Authors:  M D Bedder; R Kozody; R J Palahniuk; M O Cumming; W R Pucci
Journal:  Can Anaesth Soc J       Date:  1986-09

4.  Dexmedetomidine modulates neuroinflammation and improves outcome via alpha2-adrenergic receptor signaling after rat spinal cord injury.

Authors:  Jiandong Gao; Zhihua Sun; Zhaoyang Xiao; Qihang Du; Xinhuan Niu; Gongming Wang; Yu-Wen Chang; Yongtao Sun; Wei Sun; Amity Lin; Jacqueline C Bresnahan; Mervyn Maze; Michael S Beattie; Jonathan Z Pan
Journal:  Br J Anaesth       Date:  2019-10-14       Impact factor: 9.166

5.  Sensory Feedback in Interlimb Coordination: Contralateral Afferent Contribution to the Short-Latency Crossed Response during Human Walking.

Authors:  Sabata Gervasio; Michael Voigt; Uwe G Kersting; Dario Farina; Thomas Sinkjær; Natalie Mrachacz-Kersting
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

Review 6.  Clinical pharmacological and therapeutic considerations in general intensive care. A review.

Authors:  M L Farina; M Bonati; G Iapichino; A Pesenti; F Procaccio; L Boselli; M Langer; A Graziina; G Tognoni
Journal:  Drugs       Date:  1987-12       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.